Nonquinolone Options for the Treatment of Mycoplasma genitalium in the Era of Increased Resistance.
Michelle Doyle, Lenka A Vodstrcil, Erica L Plummer, Ivette Aguirre, Christopher K Fairley, Catriona S Bradshaw
Open Forum Infect Dis | Published : 2020
In the era of increasing macrolide- and quinolone-resistant Mycoplasma genitalium (MG), we report the efficacy of 2 nonquinolone antimicrobials in patients with limited treatment options. Pristinamycin + doxycycline cured 75% (95% CI, 64%-85%), and minocycline cured 71% (95% CI, 54%-85%) of cases. These data provide useful estimates to inform clinical practice.